TY  - GEN
AU  - Brown,Christine E
AU  - Alizadeh,Darya
AU  - Starr,Renate
AU  - Weng,Lihong
AU  - Wagner,Jamie R
AU  - Naranjo,Araceli
AU  - Ostberg,Julie R
AU  - Blanchard,M Suzette
AU  - Kilpatrick,Julie
AU  - Simpson,Jennifer
AU  - Kurien,Anita
AU  - Priceman,Saul J
AU  - Wang,Xiuli
AU  - Harshbarger,Todd L
AU  - D'Apuzzo,Massimo
AU  - Ressler,Julie A
AU  - Jensen,Michael C
AU  - Barish,Michael E
AU  - Chen,Mike
AU  - Portnow,Jana
AU  - Forman,Stephen J
AU  - Badie,Behnam
TI  - Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
SN  - 1533-4406
PY  - 2017///0110
KW  - CD8-Positive T-Lymphocytes
KW  - immunology
KW  - Cell Engineering
KW  - Combined Modality Therapy
KW  - Glioblastoma
KW  - therapy
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - Interleukin-13 Receptor alpha2 Subunit
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Receptors, Antigen, T-Cell
KW  - therapeutic use
N1  - Publication Type: Case Reports; Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1610497
ER  -